Log in to save to my catalogue

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5578041

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

About this item

Full title

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2017-07, Vol.18 (8), p.1651

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). In human placentas...

Alternative Titles

Full title

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5578041

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5578041

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms18081651

How to access this item